Logo image of ALGM

ALLEGRO MICROSYSTEMS INC (ALGM) Stock Fundamental Analysis

NASDAQ:ALGM - Nasdaq - US01749D1054 - Common Stock - Currency: USD

30.64  -0.19 (-0.62%)

After market: 30.64 0 (0%)

Fundamental Rating

4

Overall ALGM gets a fundamental rating of 4 out of 10. We evaluated ALGM against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ALGM is average, but there are quite some concerns on its profitability. ALGM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGM was profitable.
ALGM had a positive operating cash flow in the past year.
ALGM had positive earnings in 4 of the past 5 years.
In the past 5 years ALGM always reported a positive cash flow from operatings.
ALGM Yearly Net Income VS EBIT VS OCF VS FCFALGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

The Return On Assets of ALGM (-5.14%) is worse than 67.27% of its industry peers.
ALGM has a Return On Equity of -7.85%. This is in the lower half of the industry: ALGM underperforms 65.45% of its industry peers.
Industry RankSector Rank
ROA -5.14%
ROE -7.85%
ROIC N/A
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ALGM Yearly ROA, ROE, ROICALGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

The Gross Margin of ALGM (44.35%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALGM has grown nicely.
The Profit Margin and Operating Margin are not available for ALGM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
ALGM Yearly Profit, Operating, Gross MarginsALGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40

6

2. Health

2.1 Basic Checks

ALGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALGM has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALGM has less shares outstanding
Compared to 1 year ago, ALGM has a worse debt to assets ratio.
ALGM Yearly Shares OutstandingALGM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ALGM Yearly Total Debt VS Total AssetsALGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

ALGM has an Altman-Z score of 7.69. This indicates that ALGM is financially healthy and has little risk of bankruptcy at the moment.
ALGM has a Altman-Z score of 7.69. This is in the better half of the industry: ALGM outperforms 71.82% of its industry peers.
ALGM has a debt to FCF ratio of 16.66. This is a negative value and a sign of low solvency as ALGM would need 16.66 years to pay back of all of its debts.
ALGM's Debt to FCF ratio of 16.66 is in line compared to the rest of the industry. ALGM outperforms 42.73% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that ALGM is not too dependend on debt financing.
ALGM's Debt to Equity ratio of 0.37 is on the low side compared to the rest of the industry. ALGM is outperformed by 67.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 16.66
Altman-Z 7.69
ROIC/WACCN/A
WACC11.51%
ALGM Yearly LT Debt VS Equity VS FCFALGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.30 indicates that ALGM has no problem at all paying its short term obligations.
ALGM has a better Current ratio (4.30) than 66.36% of its industry peers.
A Quick Ratio of 2.66 indicates that ALGM has no problem at all paying its short term obligations.
ALGM has a Quick ratio (2.66) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.3
Quick Ratio 2.66
ALGM Yearly Current Assets VS Current LiabilitesALGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for ALGM have decreased strongly by -70.00% in the last year.
ALGM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -32.49% yearly.
Looking at the last year, ALGM shows a very negative growth in Revenue. The Revenue has decreased by -30.91% in the last year.
ALGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)-70%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-30.91%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%21.86%

3.2 Future

The Earnings Per Share is expected to grow by 83.54% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALGM will show a quite strong growth in Revenue. The Revenue will grow by 18.67% on average per year.
EPS Next Y123.13%
EPS Next 2Y101.9%
EPS Next 3Y83.54%
EPS Next 5YN/A
Revenue Next Year17.97%
Revenue Next 2Y18.23%
Revenue Next 3Y18.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALGM Yearly Revenue VS EstimatesALGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ALGM Yearly EPS VS EstimatesALGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 102.13, which means the current valuation is very expensive for ALGM.
Compared to the rest of the industry, the Price/Earnings ratio of ALGM is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.82, ALGM is valued quite expensively.
A Price/Forward Earnings ratio of 31.32 indicates a quite expensive valuation of ALGM.
ALGM's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.24. ALGM is around the same levels.
Industry RankSector Rank
PE 102.13
Fwd PE 31.32
ALGM Price Earnings VS Forward Price EarningsALGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALGM.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALGM.
Industry RankSector Rank
P/FCF 272.7
EV/EBITDA 130.47
ALGM Per share dataALGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ALGM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALGM's earnings are expected to grow with 83.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y101.9%
EPS Next 3Y83.54%

0

5. Dividend

5.1 Amount

No dividends for ALGM!.
Industry RankSector Rank
Dividend Yield N/A

ALLEGRO MICROSYSTEMS INC

NASDAQ:ALGM (8/19/2025, 4:31:34 PM)

After market: 30.64 0 (0%)

30.64

-0.19 (-0.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners85.92%
Inst Owner Change-6.39%
Ins Owners0.68%
Ins Owner Change0.55%
Market Cap5.67B
Analysts83.33
Price Target38.51 (25.69%)
Short Float %6.59%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.53%
Min EPS beat(2)5.42%
Max EPS beat(2)17.65%
EPS beat(4)4
Avg EPS beat(4)23.38%
Min EPS beat(4)5.42%
Max EPS beat(4)44.96%
EPS beat(8)8
Avg EPS beat(8)15.87%
EPS beat(12)12
Avg EPS beat(12)13.14%
EPS beat(16)16
Avg EPS beat(16)11.36%
Revenue beat(2)1
Avg Revenue beat(2)0.48%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)2.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-2.06%
Max Revenue beat(4)2.03%
Revenue beat(8)2
Avg Revenue beat(8)-0.79%
Revenue beat(12)4
Avg Revenue beat(12)-0.06%
Revenue beat(16)7
Avg Revenue beat(16)0.2%
PT rev (1m)28.69%
PT rev (3m)37.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.77%
EPS NY rev (1m)0%
EPS NY rev (3m)1.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 102.13
Fwd PE 31.32
P/S 7.82
P/FCF 272.7
P/OCF 91.52
P/B 6.1
P/tB 12.19
EV/EBITDA 130.47
EPS(TTM)0.3
EY0.98%
EPS(NY)0.98
Fwd EY3.19%
FCF(TTM)0.11
FCFY0.37%
OCF(TTM)0.33
OCFY1.09%
SpS3.92
BVpS5.03
TBVpS2.51
PEG (NY)0.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.14%
ROE -7.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.35%
FCFM 2.87%
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 16.66
Debt/EBITDA 7.59
Cap/Depr 63.77%
Cap/Sales 5.67%
Interest Coverage N/A
Cash Conversion 136.31%
Profit Quality N/A
Current Ratio 4.3
Quick Ratio 2.66
Altman-Z 7.69
F-Score3
WACC11.51%
ROIC/WACCN/A
Cap/Depr(3y)131.89%
Cap/Depr(5y)124.81%
Cap/Sales(3y)8.59%
Cap/Sales(5y)8.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y123.13%
EPS Next 2Y101.9%
EPS Next 3Y83.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.91%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%21.86%
Revenue Next Year17.97%
Revenue Next 2Y18.23%
Revenue Next 3Y18.67%
Revenue Next 5YN/A
EBIT growth 1Y-108.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.96%
EBIT Next 3Y80.06%
EBIT Next 5YN/A
FCF growth 1Y-63.51%
FCF growth 3Y-37.77%
FCF growth 5Y-10.31%
OCF growth 1Y-65.93%
OCF growth 3Y-26.53%
OCF growth 5Y-5.33%